Worldwide, the average value of enterprise value to earnings before interest, tax, depreciation and amortization (EV/EBITDA) in the health & pharmaceuticals sector as of 2023, was a multiple of approximately 14.9x. Healthcare information and technology companies saw the highest average valuation multiples as of January 2023 with 20.99x.
Average EV/EBITDA multiples in the health & pharmaceuticals sector worldwide from 2019 to 2023, by industry
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic EV/EBITDA in the health & pharmaceuticals sector in Europe 2019-2023, by industry
- Premium Statistic EV/EBITDA in energy & environmental services worldwide 2019-2023, by industry
- Premium Statistic EV/EBITDA in the transportation & logistics sector worldwide 2023, by industry
- Premium Statistic EV/EBITDA in the consumer goods & FMCG sector in Europe 2019-2023, by industry
- Premium Statistic EV/EBITDA in the consumer goods & FMCG sector worldwide 2019-2023, by industry
- Premium Statistic EV/EBITDA in the energy & environmental services sector Europe 2019-2023, by industry
- Premium Statistic Price earning in the health & pharmaceuticals sector in Europe 2023
- Premium Statistic EV/EBITDA in the technology & telecommunications sector worldwide 2023, by industry
- Premium Statistic EV/EBITDA in the media & advertising sector in Europe 2019-2023, by industry
- Premium Statistic EV/EBITDA in the retail & trade sector worldwide 2019-2023, by industry
About the region
10
- Premium Statistic EV/EBITDA in the media & advertising sector worldwide 2019-2023, by industry
- Premium Statistic EV/EBITDA in the metals & electronics sector worldwide 2019-2023, by industry
- Premium Statistic EV/EBITDA in the finance, insurance & real estate sector worldwide 2020, by industry
- Premium Statistic EV/EBITDA in metals and electronics in emerging markets 2019-2023, by industry
- Premium Statistic EV/EBITDA in chemicals and resources in emerging markets 2019-2023, by industry
- Premium Statistic EV/EBITDA in technology and telecommunications in emerging markets 2019-2023
- Premium Statistic EV/EBITDA in the construction sector in emerging markets 2019-2023, by industry
- Premium Statistic EV/EBITDA in the transportation and logistics sector in emerging markets 2019-2023
- Premium Statistic EV/EBITDA in consumer goods & FMCG in emerging markets 2019-2023, by industry
- Premium Statistic EV/EBITDA in the energy & environmental services sector in emerging markets 2019-2023
Other regions
10
- Premium Statistic EV/EBITDA in the metals & electronics sector in Europe 2019-2023, by industry
- Premium Statistic EV/EBITDA in the media and advertising sector in the U.S. 2019-2023, by industry
- Premium Statistic EV/EBITDA in the health and pharmaceuticals sector in China 2019-2023, by industry
- Premium Statistic Number of M&A deals in Italy H1 2021, by sector
- Basic Statistic COVID-19: Industries negatively affected according to PE investors DACH region 2020
- Premium Statistic Number of private equity deals in Romania 2017-2019
- Premium Statistic Healthcare average value/EBITDA Worldwide 2010-2018, by region
- Premium Statistic Media and entertainment average value/EBITDA Worldwide 2010-2018, by region
- Basic Statistic Number of M&A transactions in Asia 2015-2017, by country
- Premium Statistic M&A activity in Russia: aggregate value of transactions 2011-2021
Related statistics
10
- Premium Statistic EV/EBITDA in the retail & trade sector in Europe 2019-2023, by industry
- Premium Statistic EV/EBITDA in the technology & telecommunications sector Europe 2019-2023, by industry
- Premium Statistic EV/EBITDA in the transportation & logistics sector in Europe 2019-2023, by industry
- Premium Statistic EV/EBITDA in the consumer goods & FMCG sector in China 219-2023, by industry
- Premium Statistic Price earning in the consumer goods & FMCG in Europe 2023, by industry
- Premium Statistic EV/EBITDA in the retail and trade sector in emerging markets 2019-2023, by industry
- Premium Statistic EV/EBITDA in the finance, insurance and real estate sector in the U.S. 2019-2023
- Premium Statistic EV/EBITDA in energy & environmental services in China 2019-2023, by industry
- Premium Statistic Price earning in the finance, insurance & real estate firms in Europe 2023
- Premium Statistic EV/EBITDA in the health and pharmaceuticals sector in the U.S. 2019-2023, by industry
Further related statistics
10
- Financial advisors ranked by M&A transactions in the UK 2022, by deal value
- Employer firm revenue of residential care and nursing facilities by tax category 2021
- Biotech company distribution by geographical location
- Hugo Boss - EBITDA 2005-2023
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Net earnings of UnitedHealth Group 2007-2023
- Total assets of UnitedHealth Group 2007-2023
- Leading financial advisors to M&A deals in the UK 2022, by deal volume
- Medicaid long-term care services expenditures by type of service 1990-21
- Rate of new cases of tuberculosis in the U.S. 1960-2019
Further Content: You might find this interesting as well
Statistics
- Financial advisors ranked by M&A transactions in the UK 2022, by deal value
- Employer firm revenue of residential care and nursing facilities by tax category 2021
- Biotech company distribution by geographical location
- Hugo Boss - EBITDA 2005-2023
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Net earnings of UnitedHealth Group 2007-2023
- Total assets of UnitedHealth Group 2007-2023
- Leading financial advisors to M&A deals in the UK 2022, by deal volume
- Medicaid long-term care services expenditures by type of service 1990-21
- Rate of new cases of tuberculosis in the U.S. 1960-2019
Leonard N. Stern School of Business. (January 5, 2023). Average EV/EBITDA multiples in the health & pharmaceuticals sector worldwide from 2019 to 2023, by industry [Graph]. In Statista. Retrieved May 09, 2024, from https://www.statista.com/statistics/1030111/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-worldwide/
Leonard N. Stern School of Business. "Average EV/EBITDA multiples in the health & pharmaceuticals sector worldwide from 2019 to 2023, by industry." Chart. January 5, 2023. Statista. Accessed May 09, 2024. https://www.statista.com/statistics/1030111/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-worldwide/
Leonard N. Stern School of Business. (2023). Average EV/EBITDA multiples in the health & pharmaceuticals sector worldwide from 2019 to 2023, by industry. Statista. Statista Inc.. Accessed: May 09, 2024. https://www.statista.com/statistics/1030111/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-worldwide/
Leonard N. Stern School of Business. "Average Ev/Ebitda Multiples in The Health & Pharmaceuticals Sector Worldwide from 2019 to 2023, by Industry." Statista, Statista Inc., 5 Jan 2023, https://www.statista.com/statistics/1030111/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-worldwide/
Leonard N. Stern School of Business, Average EV/EBITDA multiples in the health & pharmaceuticals sector worldwide from 2019 to 2023, by industry Statista, https://www.statista.com/statistics/1030111/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-worldwide/ (last visited May 09, 2024)
Average EV/EBITDA multiples in the health & pharmaceuticals sector worldwide from 2019 to 2023, by industry [Graph], Leonard N. Stern School of Business, January 5, 2023. [Online]. Available: https://www.statista.com/statistics/1030111/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-worldwide/